Regulatory T cells (Tregs) are a subset of T cells that play an important role in the regulation of T-cell function. In a previous study, CD25 was used as a marker of Tregs; however, FoxP3 was recently discovered to be a valuable phenotype of Tregs. In this study, we compared the frequency of Tregs in HIV-1-infected long-term nonprogressors (LTNP), AIDS patients (AP), HIV-exposed seronegative (ES) persons, and healthy controls (HC), by using CD4+CD25+FoxP3+ as a marker of Tregs. The results showed that the frequency of Tregs in AP was significantly higher than in the LTNP, ES, and HC, which suggests that Tregs may play a role in disease progression. Another unique finding in this study is that we found a decrease of Tregs in ES.
Get full access to this article
View all access options for this article.
References
1.
FauciAS. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science, 1993; 262:1011.
2.
FauciAS, PantaleoG, StanleyS, WeissmanD. Immunopathogenic mechanisms of HIV infection. Ann Intern Med, 1996; 124:654–663.
3.
RosenbergZF, FauciAS. Immunopathogenesis of HIV infection. FASEB J, 1991; 5:2382–2390.
4.
CaoY, QinL, ZhangL, SafritJ, HoDD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med., 1995; 332:201–208.
5.
Rowland-JonesSL, McMichaelA. Immune responses in HIV-exposed seronegatives: have they repelled the virus?Curr Opin Immunol, 1995; 7:448–455.
6.
ShearerGM, ClericiM. Protective immunity against HIV infection: has nature done the experiment for us?Immunol Today, 1996; 17:21–24.
7.
RinaldoC, HuangXL, FanZFet al.High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol, 1995; 69:5838–5842.
8.
HarrerT, HarrerE, KalamsSAet al.Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection: breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol, 1996; 156:2616–2623.
9.
HayCM, RuhlDJ, BasgozNOet al.Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection. J Virol, 1999; 73:5509–5519.
10.
BettsMR, ExleyB, PriceDAet al.Characterization of functional and phenotypic changes in antiGag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc Natl Acad Sci USA, 2005; 102:4512–4517.
11.
SakaguchiS, SakaguchiN, AsanoM, ItohM, TodaM. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 1995; 155:1151–1164.
12.
BelkaidY, RouseBT. Natural regulatory T cells in infectious disease. Nat Immunol, 2005; 6:353–360.
13.
RaghavanS, HolmgrenJ. CD4+ CD25+ suppressor T cells regulate pathogen induced inflammation and disease. FEMS Immunol Med Microbiol, 2005; 44:121–127.
14.
EggenaMP, BarugahareB, JonesNet al.Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol, 2005; 174:4407–4414.
15.
Oswald-RichterK, GrillSM, ShariatNet al.HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol, 2004; 2:e198.
16.
WeissL, Donkova-PetriniV, CaccavelliL, BalboM, CarbonneilC, LevyY. Human immunodeficiency virus driven expansion of CD4t CD25t regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood, 2004; 104:3249–3256.
17.
KinterAL, HennesseyM, BellAet al.CD25(t)CD4(t) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(t) and CD8(t) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med, 2004; 200:331–343.
18.
TsunemiS, IwasakiT, ImadoTet al.Relationship of CD4t CD25t regulatory T cells to immune status in HIV-infected patients. AIDS, 2005; 19:879–886.
19.
ApoilPA, PuissantB, RoubinetF, AbbalM, MassipP, BlancherA. FOXP3 mRNA levels are decreased in peripheral blood CD4t lymphocytes from HIV-positive patients. J Acquir Immune Defic Syndr, 2005; 39:381–385.
20.
MontesM, LewisDE, SanchezCet al.Foxp3t regulatory T cells in antiretroviral-naive HIV patients. AIDS, 2006; 20:1669–1671.
21.
Curotto de LafailleMA, LafailleJJ. CD4(t) regulatory T cells in autoimmunity and allergy. Curr Opin Immunol, 2002; 14:771–778.
22.
FurtadoGC, Olivares-VillagomezD, Curotto de LafailleMA, WenskyAK, LatkowskiJA, LafailleJJ. Regulatory T cells in spontaneous autoimmune encephalomyelitis. Immunol Rev, 2001; 182:122–134.
23.
WalkerMR, KasprowiczDJ, GersukVHet al.Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4t CD25- T cells. J Clin Invest, 2003; 112:1437–1443.
24.
ZhangZ, JiangY, ZhangMet al.Relationship of frequency of CD4+ CD25+ Foxp3+ regulatory T cells with disease progression in antiretroviral-naive HIV-1 infected Chinese. Jpn J Infect Dis, 2008; 61:391–392.
25.
ThorbornG, PomeroyL, IsohanniHet al.Increased sensitivity of CD4+ T-effector cells to CD4+ CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection. PLOS One, 2010; 5:e9254.
26.
CaoW, JamiesonBD, HultinLEet al.Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. AIDS Res Hum Retroviruses, 2009; 25:183–192.
